血流感染症検査市場：製品別（機器、消耗品、ソフトウェア、サービス）、技術別（従来型、自動化）、技術別（培養ベース、分子、プロテオーム）、用途別（細菌、真菌、マイコバクテリア）、エンドユーザー別（病院、独立診断センター、その他）。世界の機会分析および産業予測、2021-2030年

Blood Stream Infection Testing Market By Product (Instruments, Consumables, Software and Services), By Technique (Conventional, Automated), By Technology (Culture-based, Molecular, Proteomic), By Application (Bacterial, Fungal, Mycobacterial), By End-users (Hospitals, Independent Diagnostics Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

血流感染症検査の世界市場は、2030年には105億4,080万ドルとなり、2022年から2030年にかけて年率8.3％で成長し、2021年には51億7,310万ドルに達すると予測されています。血流感染症とは、血液中に発見される細... もっと見る

出版社	出版年月	電子版価格	ページ数	言語
Allied Market Research アライドマーケットリサーチ	2022年7月31日	US$5,769 シングルユーザライセンスライセンス・価格情報注文方法はこちら	180	英語

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

血流感染症検査の世界市場は、2030年には105億4,080万ドルとなり、2022年から2030年にかけて年率8.3％で成長し、2021年には51億7,310万ドルに達すると予測されています。
血流感染症とは、血液中に発見される細菌、真菌、その他の種類の感染症のことです。感染が体のどの部分の血流にも入り込むとすぐに、病気が明らかになる。.血流感染症の検査は、血液感染症の原因となっている細菌やその他の生物を見つけるために行われます。人口増加や衛生環境の悪化は、様々な感染症の蔓延を招き、人々の健康に大きな脅威を与えています。血液感染症は、悪寒、寒気、発熱、下痢、嘔吐など様々な症状があり、自己診断が困難な場合があります。BSIは、高い罹患率と死亡率から、患者さんにとって懸念材料となっています。WHOによると、全世界で毎年4900万人が感染し、1100万人が死亡していると推定されています。感染症の検出と診断には、体外診断法（血液培養法）が広く用いられている。微生物検査室では、分子生物学的アプローチの技術開発により、微生物感染症の診断方法が大きく変化しています。これらの高度な技術は、より速く、より自動化され、より使いやすくなったため、ほとんどの診断室で日常的な検査やレパートリーの不可欠な一部となっています。

技術の発展とMALDI-TOFやDOTなどの自動化システムの開発により、高い所有コストと高いメンテナンス費用が市場成長の妨げになると予測されます。また、高価な検査技術により手が届かなくなる可能性があり、これが血流感染検査市場の動向を阻害すると予測されます。保険や診療報酬の規制がないため、市場拡大が制約される可能性があります。

敗血症や菌血症の世界的な増加は、血流感染症検査市場を牽引すると予測されます。菌血症や敗血症は、米国における死亡率の上位を占める原因の一つであり、毎日600人以上の死者を出しています。迅速な診断の必要性と血流感染検査における最近の進歩が、市場の成長を後押しすると期待されています。また、免疫力の低下により感染しやすい高齢者の血流感染症が増加していることも、血流感染症検査市場の成長を後押しすると予想されます。

2020年に発生したCOVID-19の流行は、世界経済に悪影響を及ぼし、世界規模で公衆衛生上の災難を引き起こした。しかし、COVID-19は世界の血流感染症検査市場に好影響を与えた。
血液培養は病気や病原体を特定するためのゴールドスタンダードであり、パンデミックにおいてBSI検査は急激に普及した。COVID-19の患者さんにおける血流感染症の発症率は0.863%であるのに対し、COVIDを使用していない患者さんは0.437%であることが判明しています。北米や欧州での事例が増加し、血流検査市場の拡大を加速させた。感染症や微生物を診断するニーズが大幅に増加した。
世界の血流感染検査市場の主な主要企業は、Thermo Fisher Scientific、F. Hoffmann-La Roche Ltd.、Abbott、BD、BIOMÉRIEUX、Cepheid、Luminex Corporation、Accelerate Diagnostics Inc.、AdvanDX、Brukerです。

ステークホルダーにとっての主なメリット
●本レポートは、2021年から2030年までの血流感染検査市場分析の市場セグメント、現在のトレンド、予測、ダイナミクスを定量的に分析し、血流感染検査市場の優勢な機会を特定します。
●市場調査は、主要な推進要因、阻害要因、機会に関連する情報とともに提供されます。
ポーターのファイブフォース分析により、買い手と供給者の潜在力を明らかにし、ステークホルダーが利益志向のビジネス決定を行い、供給者と買い手のネットワークを強化できるようにします。
血流感染症検査市場のセグメンテーションの詳細な分析は、市場機会を決定するのに役立ちます。
血流感染症検査市場の詳細な分析は、市場機会を決定するのに役立ちます。
市場プレイヤーのポジショニングは、ベンチマークを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
地域別、世界別の血流感染症検査市場動向、キープレイヤー、市場セグメント、アプリケーション分野、市場成長戦略などの分析が含まれています。

主な市場セグメント
製品別
インスツルメント
消耗品
ソフトウエア・サービス
技術別
従来型
自動化
技術別
培養系
分子系
プロテオミクス
アプリケーション別
細菌
真菌
マイコバクテリア
エンドユーザー別
病院
病院 ●独立診断センター
その他
地域別
北米
米国
カナダ
メキシコ
欧州
ドイツ
フランス
英国
イタリア
イタリア ●スペイン
欧州各地域
アジア・パシフィック
日本
中国
インド
インド ●オーストラリア
韓国
その他のアジア太平洋地域
ラメア
ブラジル
ブラジル ●サウジアラビア
サウジアラビア ●アラブ首長国連邦
南アフリカ
ラメア地域以外

主要市場セグメント
技術別
培養ベース
分子生物学的手法
プロテオミクス
製品別
インストルメント
消耗品
ソフトウェア・サービス
技術別
コンベンショナル
自動化
アプリケーション別
バクテリア
真菌
マイコバクテリア
エンドユーザー別
病院
独立系診断センター
その他

地域別
北米
米国
カナダ
メキシコ
欧州
ドイツ
イギリス
フランス
スペイン
イタリア
その他の地域
アジア・パシフィック
中国
日本
インド
韓国
オーストラリア
その他のアジア太平洋地域
LAMEA
ブラジル
サウジアラビア
アラブ首長国連邦
南アフリカ
LAMEAの他の地域

主な市場関係者
サーモフィッシャーサイエンティフィック(株)
F. ホフマン・ラ・ロシュ社
アボット・ラボラトリーズ
ベクトン・ディッキンソンメディカルデバイス社、蘇州
ビオメリュー SA
セファイド
ルミネックスコーポレーション
アクセラレート・ダイアグノスティックス
AdvanDx
ブルカー・コーポレーション

ページTOPに戻る

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Value Chain Analysis
3.8.Market Share Analysis
3.9.Regulatory Guidelines
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: BLOOD STREAM INFECTION TESTING MARKET, BY PRODUCT
4.1 Overview
4.1.1 Market size and forecast
4.2 Instruments
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Consumables
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.4 Software and Services
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: BLOOD STREAM INFECTION TESTING MARKET, BY TECHNIQUE
5.1 Overview
5.1.1 Market size and forecast
5.2 Conventional
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 Automated
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: BLOOD STREAM INFECTION TESTING MARKET, BY TECHNOLOGY
6.1 Overview
6.1.1 Market size and forecast
6.2 Culture-based
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Molecular
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Proteomic
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
CHAPTER 7: BLOOD STREAM INFECTION TESTING MARKET, BY APPLICATION
7.1 Overview
7.1.1 Market size and forecast
7.2 Bacterial
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Fungal
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Mycobacterial
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: BLOOD STREAM INFECTION TESTING MARKET, BY END-USERS
8.1 Overview
8.1.1 Market size and forecast
8.2 Hospitals
8.2.1 Key market trends, growth factors and opportunities
8.2.2 Market size and forecast, by region
8.2.3 Market analysis by country
8.3 Independent Diagnostics Centers
8.3.1 Key market trends, growth factors and opportunities
8.3.2 Market size and forecast, by region
8.3.3 Market analysis by country
8.4 Others
8.4.1 Key market trends, growth factors and opportunities
8.4.2 Market size and forecast, by region
8.4.3 Market analysis by country
CHAPTER 9: BLOOD STREAM INFECTION TESTING MARKET, BY REGION
9.1 Overview
9.1.1 Market size and forecast
9.2 North America
9.2.1 Key trends and opportunities
9.2.2 North America Market size and forecast, by Product
9.2.3 North America Market size and forecast, by Technique
9.2.4 North America Market size and forecast, by Technology
9.2.5 North America Market size and forecast, by Application
9.2.6 North America Market size and forecast, by End-users
9.2.7 North America Market size and forecast, by country
9.2.7.1 U.S.
9.2.7.1.1 Market size and forecast, by Product
9.2.7.1.2 Market size and forecast, by Technique
9.2.7.1.3 Market size and forecast, by Technology
9.2.7.1.4 Market size and forecast, by Application
9.2.7.1.5 Market size and forecast, by End-users
9.2.7.2 Canada
9.2.7.2.1 Market size and forecast, by Product
9.2.7.2.2 Market size and forecast, by Technique
9.2.7.2.3 Market size and forecast, by Technology
9.2.7.2.4 Market size and forecast, by Application
9.2.7.2.5 Market size and forecast, by End-users
9.2.7.3 Mexico
9.2.7.3.1 Market size and forecast, by Product
9.2.7.3.2 Market size and forecast, by Technique
9.2.7.3.3 Market size and forecast, by Technology
9.2.7.3.4 Market size and forecast, by Application
9.2.7.3.5 Market size and forecast, by End-users
9.3 Europe
9.3.1 Key trends and opportunities
9.3.2 Europe Market size and forecast, by Product
9.3.3 Europe Market size and forecast, by Technique
9.3.4 Europe Market size and forecast, by Technology
9.3.5 Europe Market size and forecast, by Application
9.3.6 Europe Market size and forecast, by End-users
9.3.7 Europe Market size and forecast, by country
9.3.7.1 Germany
9.3.7.1.1 Market size and forecast, by Product
9.3.7.1.2 Market size and forecast, by Technique
9.3.7.1.3 Market size and forecast, by Technology
9.3.7.1.4 Market size and forecast, by Application
9.3.7.1.5 Market size and forecast, by End-users
9.3.7.2 United Kingdom
9.3.7.2.1 Market size and forecast, by Product
9.3.7.2.2 Market size and forecast, by Technique
9.3.7.2.3 Market size and forecast, by Technology
9.3.7.2.4 Market size and forecast, by Application
9.3.7.2.5 Market size and forecast, by End-users
9.3.7.3 France
9.3.7.3.1 Market size and forecast, by Product
9.3.7.3.2 Market size and forecast, by Technique
9.3.7.3.3 Market size and forecast, by Technology
9.3.7.3.4 Market size and forecast, by Application
9.3.7.3.5 Market size and forecast, by End-users
9.3.7.4 Spain
9.3.7.4.1 Market size and forecast, by Product
9.3.7.4.2 Market size and forecast, by Technique
9.3.7.4.3 Market size and forecast, by Technology
9.3.7.4.4 Market size and forecast, by Application
9.3.7.4.5 Market size and forecast, by End-users
9.3.7.5 Italy
9.3.7.5.1 Market size and forecast, by Product
9.3.7.5.2 Market size and forecast, by Technique
9.3.7.5.3 Market size and forecast, by Technology
9.3.7.5.4 Market size and forecast, by Application
9.3.7.5.5 Market size and forecast, by End-users
9.3.7.6 Rest of Europe
9.3.7.6.1 Market size and forecast, by Product
9.3.7.6.2 Market size and forecast, by Technique
9.3.7.6.3 Market size and forecast, by Technology
9.3.7.6.4 Market size and forecast, by Application
9.3.7.6.5 Market size and forecast, by End-users
9.4 Asia-Pacific
9.4.1 Key trends and opportunities
9.4.2 Asia-Pacific Market size and forecast, by Product
9.4.3 Asia-Pacific Market size and forecast, by Technique
9.4.4 Asia-Pacific Market size and forecast, by Technology
9.4.5 Asia-Pacific Market size and forecast, by Application
9.4.6 Asia-Pacific Market size and forecast, by End-users
9.4.7 Asia-Pacific Market size and forecast, by country
9.4.7.1 China
9.4.7.1.1 Market size and forecast, by Product
9.4.7.1.2 Market size and forecast, by Technique
9.4.7.1.3 Market size and forecast, by Technology
9.4.7.1.4 Market size and forecast, by Application
9.4.7.1.5 Market size and forecast, by End-users
9.4.7.2 Japan
9.4.7.2.1 Market size and forecast, by Product
9.4.7.2.2 Market size and forecast, by Technique
9.4.7.2.3 Market size and forecast, by Technology
9.4.7.2.4 Market size and forecast, by Application
9.4.7.2.5 Market size and forecast, by End-users
9.4.7.3 India
9.4.7.3.1 Market size and forecast, by Product
9.4.7.3.2 Market size and forecast, by Technique
9.4.7.3.3 Market size and forecast, by Technology
9.4.7.3.4 Market size and forecast, by Application
9.4.7.3.5 Market size and forecast, by End-users
9.4.7.4 South Korea
9.4.7.4.1 Market size and forecast, by Product
9.4.7.4.2 Market size and forecast, by Technique
9.4.7.4.3 Market size and forecast, by Technology
9.4.7.4.4 Market size and forecast, by Application
9.4.7.4.5 Market size and forecast, by End-users
9.4.7.5 Australia
9.4.7.5.1 Market size and forecast, by Product
9.4.7.5.2 Market size and forecast, by Technique
9.4.7.5.3 Market size and forecast, by Technology
9.4.7.5.4 Market size and forecast, by Application
9.4.7.5.5 Market size and forecast, by End-users
9.4.7.6 Rest of Asia-Pacific
9.4.7.6.1 Market size and forecast, by Product
9.4.7.6.2 Market size and forecast, by Technique
9.4.7.6.3 Market size and forecast, by Technology
9.4.7.6.4 Market size and forecast, by Application
9.4.7.6.5 Market size and forecast, by End-users
9.5 LAMEA
9.5.1 Key trends and opportunities
9.5.2 LAMEA Market size and forecast, by Product
9.5.3 LAMEA Market size and forecast, by Technique
9.5.4 LAMEA Market size and forecast, by Technology
9.5.5 LAMEA Market size and forecast, by Application
9.5.6 LAMEA Market size and forecast, by End-users
9.5.7 LAMEA Market size and forecast, by country
9.5.7.1 Brazil
9.5.7.1.1 Market size and forecast, by Product
9.5.7.1.2 Market size and forecast, by Technique
9.5.7.1.3 Market size and forecast, by Technology
9.5.7.1.4 Market size and forecast, by Application
9.5.7.1.5 Market size and forecast, by End-users
9.5.7.2 Saudi Arabia
9.5.7.2.1 Market size and forecast, by Product
9.5.7.2.2 Market size and forecast, by Technique
9.5.7.2.3 Market size and forecast, by Technology
9.5.7.2.4 Market size and forecast, by Application
9.5.7.2.5 Market size and forecast, by End-users
9.5.7.3 United Arab Emirates
9.5.7.3.1 Market size and forecast, by Product
9.5.7.3.2 Market size and forecast, by Technique
9.5.7.3.3 Market size and forecast, by Technology
9.5.7.3.4 Market size and forecast, by Application
9.5.7.3.5 Market size and forecast, by End-users
9.5.7.4 South Africa
9.5.7.4.1 Market size and forecast, by Product
9.5.7.4.2 Market size and forecast, by Technique
9.5.7.4.3 Market size and forecast, by Technology
9.5.7.4.4 Market size and forecast, by Application
9.5.7.4.5 Market size and forecast, by End-users
9.5.7.5 Rest of LAMEA
9.5.7.5.1 Market size and forecast, by Product
9.5.7.5.2 Market size and forecast, by Technique
9.5.7.5.3 Market size and forecast, by Technology
9.5.7.5.4 Market size and forecast, by Application
9.5.7.5.5 Market size and forecast, by End-users
CHAPTER 10: COMPANY LANDSCAPE
10.1. Introduction
10.2. Top winning strategies
10.3. Product Mapping of Top 10 Player
10.4. Competitive Dashboard
10.5. Competitive Heatmap
10.6. Key developments
CHAPTER 11: COMPANY PROFILES
11.1 Thermo Fisher Scientific, Inc.
11.1.1 Company overview
11.1.2 Company snapshot
11.1.3 Operating business segments
11.1.4 Product portfolio
11.1.5 Business performance
11.1.6 Key strategic moves and developments
11.2 F. Hoffmann-La Roche Ltd.
11.2.1 Company overview
11.2.2 Company snapshot
11.2.3 Operating business segments
11.2.4 Product portfolio
11.2.5 Business performance
11.2.6 Key strategic moves and developments
11.3 Abbott Laboratories
11.3.1 Company overview
11.3.2 Company snapshot
11.3.3 Operating business segments
11.3.4 Product portfolio
11.3.5 Business performance
11.3.6 Key strategic moves and developments
11.4 becton dickinson medical devices co. ltd., suzhou
11.4.1 Company overview
11.4.2 Company snapshot
11.4.3 Operating business segments
11.4.4 Product portfolio
11.4.5 Business performance
11.4.6 Key strategic moves and developments
11.5 bioMérieux SA
11.5.1 Company overview
11.5.2 Company snapshot
11.5.3 Operating business segments
11.5.4 Product portfolio
11.5.5 Business performance
11.5.6 Key strategic moves and developments
11.6 cepheid
11.6.1 Company overview
11.6.2 Company snapshot
11.6.3 Operating business segments
11.6.4 Product portfolio
11.6.5 Business performance
11.6.6 Key strategic moves and developments
11.7 Luminex Corporation
11.7.1 Company overview
11.7.2 Company snapshot
11.7.3 Operating business segments
11.7.4 Product portfolio
11.7.5 Business performance
11.7.6 Key strategic moves and developments
11.8 Accelerate Diagnostics Inc.
11.8.1 Company overview
11.8.2 Company snapshot
11.8.3 Operating business segments
11.8.4 Product portfolio
11.8.5 Business performance
11.8.6 Key strategic moves and developments
11.9 AdvanDx
11.9.1 Company overview
11.9.2 Company snapshot
11.9.3 Operating business segments
11.9.4 Product portfolio
11.9.5 Business performance
11.9.6 Key strategic moves and developments
11.10 Bruker Corporation
11.10.1 Company overview
11.10.2 Company snapshot
11.10.3 Operating business segments
11.10.4 Product portfolio
11.10.5 Business performance
11.10.6 Key strategic moves and developments

ページTOPに戻る

Table of Contents

Summary

The global blood stream infection testing market was valued at $10,540.8 million by 2030, and is anticipated to reach $5,173.1 million in 2021, growing at a CAGR of 8.3% from 2022 to 2030.
A blood stream infection is any bacterial, fungal, or other type of infection that is discovered in the blood. As soon as the infection enters the bloodstream of any part of the body, the illness becomes evident. . Testing for blood stream infections is done to find out which bacteria or other organisms are responsible for the blood infections. The ongoing population growth and worsening of sanitary conditions pose a serious threat to human health since they encourage the spread of various infectious illnesses. Due to the vast range of symptoms associated with bloodstream infections, including chills, cold, fever, diarrhea, and vomiting, self-diagnosis can be difficult. The BSI is concern for patient due to high morbidity and mortality rates. According to WHO It is estimated 49 million people and causes 11 million deaths globally every year. For detection and diagnosis of the infection, the in-vitro diagnostic techniques (blood cultures) are widely used. In the microbiology laboratory, technological developments in molecular approaches have transformed the approach of diagnosing microbial infections. As theses sophisticated technologies have become faster, more automated, and easier to use, they have become essential part of routine testing and repertoire in most diagnostic laboratories.

As technology develops and automated systems such as MALDI-TOF and DOT are developed, high cost of ownership and high maintenance expenses are projected to hinder the market growth. Also, costly testing techniques may make them unaffordable and this is projected to hamper the blood stream infection testing market trend. Market expansion can be constrained due to lack of insurance and reimbursement regulations.

The increase in the number of sepsis and bacteremia globally is expected to drive the blood stream infection testing market. Bacteremia and sepsis are few of the top causes of mortality rate in United States, causing over 600 fatalities each day. The need for rapid diagnosis and recent advancement in bloodstream infection testing are expected to boost the market growth. The increasing incidences of bloodstream infection in elderly population who are susceptible to infection due to low immunity is anticipate to drive the demand for blood stream infection testing market growth.

The COVID-19 epidemic in 2020 adversely affected the world's economy and triggered a public health calamity on a worldwide scale. However, the COVID-19 had a positive effect on the market for testing for blood stream infections worldwide.
Blood culture is the gold standard for identifying an illness or pathogen, thus in pandemic BSI testing has seen a sharp rise in popularity. The incidence rate of blood stream infection in COVID-19 patients was discovered to be 0.863% compared to patients without COVID having 0.437%. The rise in instances in North America and Europe accelerated the expansion of blood stream testing market. The need for infections or microorganisms to be diagnosed increased significantly.
The major key players in the global blood stream infection testing market are Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd., Abbott, BD, BIOMÉRIEUX, Cepheid, Luminex Corporation, Accelerate Diagnostics Inc., AdvanDX, and Bruker.

Key Benefits For Stakeholders
●This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the blood stream infection testing market analysis from 2021 to 2030 to identify the prevailing blood stream infection testing market opportunities.
●The market research is offered along with information related to key drivers, restraints, and opportunities.
●Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
●In-depth analysis of the blood stream infection testing market segmentation assists to determine the prevailing market opportunities.
●Major countries in each region are mapped according to their revenue contribution to the global market.
●Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
●The report includes the analysis of the regional as well as global blood stream infection testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments
●By Product
●Instrument
●Consumables
●Software & Services
●By Technique
●Conventional
●Automated
●By technology
●Culture-based
●Molecular
●Proteomic
●By Application
●Bacterial
●Fungal
●Mycobacterial
●By End-user
●Hospitals
●Independent Diagnostics Centers
●Others
●By Region
●North America
●U.S.
●Canada
●Mexico
●Europe
●Germany
●France
●U.K.
●Italy
●Spain
●Rest of Europe
●Asia-Pacific
●Japan
●China
●India
●Australia
●South Korea
●Rest of Asia-Pacific
●LAMEA
●Brazil
●Saudi Arabia
●United Arab Emirates
●South Africa
●Rest of LAMEA

Key Market Segments
By Technology
● Culture-based
● Molecular
● Proteomic
By Product
● Instruments
● Consumables
● Software and Services
By Technique
● Conventional
● Automated
By Application
● Bacterial
● Fungal
● Mycobacterial
By End-users
● Hospitals
● Independent Diagnostics Centers
● Others

By Region
● North America
○ U.S.
○ Canada
○ Mexico
● Europe
○ Germany
○ United Kingdom
○ France
○ Spain
○ Italy
○ Rest of Europe
● Asia-Pacific
○ China
○ Japan
○ India
○ South Korea
○ Australia
○ Rest of Asia-Pacific
● LAMEA
○ Brazil
○ Saudi Arabia
○ United Arab Emirates
○ South Africa
○ Rest of LAMEA

● Key Market Players
○ Thermo Fisher Scientific, Inc.
○ F. Hoffmann-La Roche Ltd.
○ Abbott Laboratories
○ becton dickinson medical devices co. ltd., suzhou
○ bioMérieux SA
○ cepheid
○ Luminex Corporation
○ Accelerate Diagnostics Inc.
○ AdvanDx
○ Bruker Corporation

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（診断薬）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（automated）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

アライドマーケットリサーチ（Allied Market Research）は世界の多様な市場に関する戦略や将来推計、成長/衰退予測、機会分析、消費者調査などを行い、市場調査レポートを積極的に出版しています。もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（診断薬）の最新刊レポート

Allied Market Research 社の最新刊レポート

本レポートと同じKEY WORD（automated）の最新刊レポート

よくあるご質問

Allied Market Research社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?